AURYXIA® (ferric citrate) is indicated for:
AURYXIA® (ferric citrate) is contraindicated in patients with iron overload syndromes, e.g., hemochromatosis
The most common adverse reactions reported with AURYXIA in clinical trials were:
To report suspected adverse reactions, contact Akebia Therapeutics, Inc. at 1-844-445-3799
Please see full Prescribing Information